Tradestie Institutional Equity Comparison Engine

CAPR vs EDIT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CAPR Overall Edge

CAPR Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Capricor Therapeutics Inc (CAPR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CAPR trades at 78.7x Forward P/E with 0.0% operating margin (-7.9% YoY revenue) versus EDIT at N/M Forward P/E and -167.0% operating margin (+37.4% YoY). In options structure, CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro) against EDIT sits in BREAKDOWN (38th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CAPR
CAPR 78.7x vs EDIT N/M Fwd P/E
Growth & Margin Winner CAPR
Op Margin 0.0% vs -167.0% ยท YoY -7.9% vs +37.4%
Momentum & Technical Winner CAPR
1Y +44.3% vs -25.0% ยท 52W Pos 15% vs 11%
Options & Structure Winner CAPR
CONSOLIDATION (89th %ile IV) vs BREAKDOWN (38th %ile IV)
CAPR NASDAQ
Capricor Therapeutics Inc
Pharmaceutical Preparations
$8.47
-11.12% 1D
Market Cap $595.4M
1M Return +26.23%
1Y Return +44.29%
Forward P/E 78.7x
Unified AI Score
28.0 / 100 SELL
Tech 50.0 Fund 37.0 Flow 68.0 Mom 50.0
EDIT NASDAQ
Editas Medicine, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.91
-12.21% 1D
Market Cap $336.5M
1M Return -18.94%
1Y Return -25.0%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 33.0 Fund 55.0 Flow 69.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CAPR +44.29% EDIT -25.0% Spread: +71.79 pp (CAPR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CAPR Revenue EDIT Revenue CAPR Op. Margin EDIT Op. Margin Margin Edge
FY2018 $0M $30M -917.0% -356.1% EDIT
FY2019 $0M $20M -769.5% -686.4% EDIT
FY2020 $0M $90M -4412.6% -148.6% EDIT
FY2021 $0M $30M -8549.9% -756.1% EDIT
FY2022 $0M $20M -1163.9% -1146.3% EDIT
FY2023 $30M $80M -95.6% -216.6% CAPR
FY2024 $20M $30M -191.1% -777.2% CAPR
FY2025 N/A $40M N/A -394.9% EDIT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CAPR (7) vs EDIT (3)
Institutional Metric CAPR EDIT Criterion Row Winner
Market Capitalization Scale $595.4M $336.5M Larger Scale CAPR
Trailing P/E Ratio Valuation 78.7x N/M Lower Multiple CAPR
Forward P/E Ratio Valuation 78.7x N/M Lower Multiple CAPR
Revenue Growth (YoY) Growth -7.9% +37.4% Higher Growth EDIT
Operating Margin (TTM) Profitability 0.0% -167.0% Higher Margin CAPR
Net Profit Margin Profitability 0.0% -144.9% Higher Margin CAPR
Return on Equity (ROE) Capital Efficiency -100.5% -147.4% Higher ROE CAPR
52-Week Range Position Momentum 15% ($3โ€“$40) 11% ($2โ€“$4) Stronger Trend CAPR
Beta / 30D Volatility Risk Regime 1.52ฮฒ ยท 152% Vol 2.32ฮฒ ยท 102% Vol Lower Realized Risk EDIT
Unified Institutional Score Composite Signal 28.0 / 100 (SELL) 48.4 / 100 (HOLD) Higher Composite EDIT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CAPR vs EDIT Buy Guide
CAPR CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 89th %ile
IV Regime Extreme (>80th %ile)
Live CAPR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EDIT BREAKDOWN
146d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EDIT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CAPR nor EDIT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.